期刊文献+

注射重组人粒细胞刺激因子后糖尿病病人外周血白细胞峰值时间及不良反应的临床观察 被引量:1

Clinical observation on peak time of peripheral blood leucocyte and side effects in diabetic patients after injection of granulocyte-colony stimulating factor
下载PDF
导出
摘要 [目的]观察糖尿病病人注射重组人粒细胞刺激因子(G-CSF)后外周血白细胞峰值时间及不良反应。[方法]100例注射重组人粒细胞刺激因子糖尿病病人,每天在注射后的4个时间段采集血常规,观察不同时间的白细胞数值以及不良反应。[结果]白细胞峰值出现的时间第1天为注射后6 h、9 h;第2天~第4天为6 h;男女无差别,不同G-CSF注射剂量峰值无差异。第3天、第4天病人不良反应相对集中。[结论]临床医师可参考病人注射G-CSF后白细胞出现高峰的时间进行外周血采集。 Objective:To observe the peak time of peripheral blood leucocyte and adverse reactions in diabetic patients after injecting granulocyte-colony stimulating factor(G-CSF).Methods:A total of 100 diabetic patients who accepted the injection of G-CSF were selected and they were collected the blood routine at 4 time points after the injection every day,then to observe WBC numerical value and adverse reactions at different time points.Results:The peak time of peripheral blood leucocyte was 6h and 9h after the injection at the first day;while 6h after the injection from the second day to the fourth day.There was no significant difference between men and women,and there was no significant difference in the peak time of different G-CSF injection dose.Patients'adverse reactions were relative concentration at the third and fourth day.Conclusion:Clinicians can collecte the peripheral blood,with consulting the peak time of leucocyte present after injection of G-CSF Being.
机构地区 航天中心医院
出处 《护理研究(下旬版)》 2011年第4期1050-1051,共2页 Chinese Nursing Researsh
关键词 G-CSF 糖尿病 白细胞峰值 G-CSF diabetic WBC numerical
  • 相关文献

参考文献3

二级参考文献18

  • 1陆道培.骨髓移植的预处理方案[A].陆道培主编.白血病治疗学 第1版[C].北京:科学出版社,1992.327-331. 被引量:4
  • 2Nawa Y, Teshima T, Sunami K, et al. G-CSF reduces IFN-γ and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplant, 2000, 25:1035-1040. 被引量:1
  • 3Bacigalupo A, van Lint MT, Valbonesi M, et al. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. Blood, 1996, 88: 353-357. 被引量:1
  • 4Trenschel R, Ross S, Husing J, et al. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogenenic PBSCT. Bone Marrow Transplant, 2000,25:665-672. 被引量:1
  • 5Strob R, Deeg HJ, Farewell V, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood, 1986, 68:119-125. 被引量:1
  • 6Thomas ED, Strob R, Clift RA, et al. Bone marrow transplantation (second of the two part). N Engl J Med, 1975, 292: 895-902. 被引量:1
  • 7Bensiger WI, Clift R, Martin P, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood, 1996, 88: 2794-2799. 被引量:1
  • 8Champlin R, Schmitz N, Mary M, et al.Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood, 2000, 95:3702-3709. 被引量:1
  • 9Russel JA, Brown T, Brown C, et al. Allogeneic blood cell transplants for hematological malignancy: comparison of engraftment and graft-versus-host disease with bone marrow transplantation. Bone Marrow Transplant, 1996, 17:703-708. 被引量:1
  • 10Pan L, Delmonte J, Jalonen DK, et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytoking production and reduces severity of esperimental graft-versus-host-disease. Blood, 1995, 86:4422-4429. 被引量:1

共引文献29

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部